CBSE Class 12 Accountancy Deleted Syllabus 2025–26 - The Central Board of Secondary Education (CBSE) has released the details regarding the CBSE Class 12 Accountancy Deleted Syllabus for the Academic ...

The Central Board of Secondary Education (CBSE) has issued the CBSE Class 12 Business Studies Deleted Syllabus for the Academic Session 2025–26, detailing the specific units and topics removed or ...

KUALA LUMPUR: Kenanga Investment Bank Bhd has emerged as the largest institutional shareholder in digital asset fund manager Halogen Capital Sdn Bhd with a 14.9% stake following the completion of its ...

The Commodity Futures Trading Commission will allow Bitcoin, Ether, and the dollar-pegged stablecoin USDC to be used as collateral for derivatives trades, a decision that pushes crypto deeper into the ...

MUMBAI, Dec 16 (Reuters) - A panel set up by India's market regulator will recommend easing curbs on commodity derivatives and suggest steps to make it more attractive to institutional investors in a ...

National Stock Exchange of India (NSE) has rolled out a pre-open trading session for equity derivatives (F&O) from December 8, creating a structured call auction window to stabilise market openings ...

Jaecoo has bolstered its J5 SUV range with the new Core model derivative. Sitting beneath the J5 Vortex, this entry-level offering rides on 17″ alloy wheels and comes standard with automatic halogen ...

Given encouraging efficacy and safety, the trial will continue as planned and further updates are anticipated in 1H CY2026 including presentation of data at a major medical conference SYDNEY, ...

Republican Rep. Nancy Mace told CNN on Tuesday that her constituents say affordability is the most important issue in South Carolina, contradicting President Donald Trump, who has insisted the issue ...

Iran has launched a trio of new satellites into space with the help of a Russian rocket, the country's state media reported Sunday (Dec. 28). We saw quite a few milestones notched in the final ...

An announcement from Immutep Ltd ( (AU:IMM)) is now available. Immutep reported encouraging interim data from a first-in-human Phase I trial of IMP761, its first-in-class LAG-3 agonist antibody ...